India approves anti-Covid oral drug for emergency use

New Delhi - According to ministry, it accumulates in the infected cells and prevents virus growth.

The Drugs Controller General of India (DCGI) has approved an anti-Covid oral drug for emergency use as an adjunct therapy in moderate to severe patients.

“On May 01, the DCGI granted permission for emergency use of this drug as adjunct therapy in moderate to severe Covid-19 patients,” said a press release from the Indian defence ministry. “Being a generic molecule and analogue of glucose, it can be easily produced and made available in plenty in the country.”

According to the ministry, it accumulates in the infected cells and prevents virus growth by stopping viral synthesis and energy production. “Its selective accumulation in virally-infected cells makes this drug unique,” added the release. The drug will be of immense benefit to people suffering from Covid-19, it pointed out.

The drug in powder form is packed in a sachet and can be taken orally by dissolving it in water. It then accumulates in the virus-infected cells and prevents its growth by stopping viral synthesis and energy production.